These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 17982409)

  • 1. Principles and indications of chronic transfusion therapy for children with sickle cell disease.
    Ware R
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):686-8. PubMed ID: 17982409
    [No Abstract]   [Full Text] [Related]  

  • 2. New treatments of sickle cell disease.
    Embury SH
    West J Med; 1996 May; 164(5):444. PubMed ID: 8686307
    [No Abstract]   [Full Text] [Related]  

  • 3. Sickle cell anaemia: current therapies.
    Vermylen C
    Transfus Apher Sci; 2013 Oct; 49(2):151-4. PubMed ID: 23954416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of sickle cell disease.
    Steinberg MH
    N Engl J Med; 1999 Apr; 340(13):1021-30. PubMed ID: 10099145
    [No Abstract]   [Full Text] [Related]  

  • 5. Sickle cell disease in North Europe.
    Howard J; Davies SC
    Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of sickle cell disease].
    de Montalembert M
    Rev Prat; 2004 Sep; 54(14):1557-64. PubMed ID: 15558966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial septal defect closure on cardiopulmonary bypass in a sickle cell anemia: role of hydroxyurea and partial exchange transfusion.
    Gosavi KS; Dash SK; Shah BN; Upasani CB
    Ann Card Anaesth; 2010; 13(2):145-7. PubMed ID: 20442545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we still be focused on red cell hemoglobin F as the principal explanation for the salutary effect of hydroxyurea in sickle cell disease?
    Segel GB; Simon W; Lichtman MA
    Pediatr Blood Cancer; 2011 Jul; 57(1):8-9. PubMed ID: 21480473
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A; Ware RE; Thornburg CD
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell disease--pathophysiology and treatment.
    Redding-Lallinger R; Knoll C
    Curr Probl Pediatr Adolesc Health Care; 2006; 36(10):346-76. PubMed ID: 17055417
    [No Abstract]   [Full Text] [Related]  

  • 11. Sickle cell disease: new insights into pathophysiology and treatment.
    Inati A; Koussa S; Taher A; Perrine S
    Pediatr Ann; 2008 May; 37(5):311-21. PubMed ID: 18543542
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N
    Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell patients find a brand New World.
    Noonan SS
    N J Med; 1999 Aug; 96(8):23-5. PubMed ID: 10457727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.
    Wang WC; Morales KH; Scher CD; Styles L; Olivieri N; Adams R; Brambilla D;
    J Pediatr; 2005 Aug; 147(2):244-7. PubMed ID: 16126058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome.
    Brachet C; Azzi N; Demulder A; Devalck C; Gourdin A; Gulbis B; Klein A; Le PQ; Loop M; Sariban E; Ferster A
    Bone Marrow Transplant; 2004 Apr; 33(8):799-803. PubMed ID: 14767501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea for children with sickle cell disease.
    Heeney MM; Ware RE
    Pediatr Clin North Am; 2008 Apr; 55(2):483-501, x. PubMed ID: 18381097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa?].
    De Montalembert M; Tshilolo L
    Med Trop (Mars); 2007 Dec; 67(6):612-6. PubMed ID: 18300525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results and current indications of bone marrow allograft in sickle cell disease].
    Bernaudin F
    Pathol Biol (Paris); 1999 Jan; 47(1):59-64. PubMed ID: 10081781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea in very young children with sickle cell anemia is not a cure-all.
    Powars DR
    J Pediatr; 2001 Dec; 139(6):763-4. PubMed ID: 11743496
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia.
    DeBaun MR
    J Pediatr; 2005 Oct; 147(4):560-1. PubMed ID: 16227052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.